18 reports of this reaction
1.7% of all FERROSOFERRIC PHOSPHATE reports
#10 most reported adverse reaction
EYE PAIN is the #10 most commonly reported adverse reaction for FERROSOFERRIC PHOSPHATE, manufactured by DNA Labs. There are 18 FDA adverse event reports linking FERROSOFERRIC PHOSPHATE to EYE PAIN. This represents approximately 1.7% of all 1,043 adverse event reports for this drug.
Patients taking FERROSOFERRIC PHOSPHATE who experience eye pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE PAIN is a less commonly reported adverse event for FERROSOFERRIC PHOSPHATE, but still significant enough to appear in the safety profile.
In addition to eye pain, the following adverse reactions have been reported for FERROSOFERRIC PHOSPHATE:
The following drugs have also been linked to eye pain in FDA adverse event reports:
EYE PAIN has been reported as an adverse event in 18 FDA reports for FERROSOFERRIC PHOSPHATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE PAIN accounts for approximately 1.7% of all adverse event reports for FERROSOFERRIC PHOSPHATE, making it a notable side effect.
If you experience eye pain while taking FERROSOFERRIC PHOSPHATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.